Cardiac Disease: Clinical Trials

8 trials for Cardiac Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 completed, 2 not yet recruiting, 1 recruiting. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Terminated 3, Completed 2, Not yet recruiting 2, Recruiting 1

Follow Cardiac Disease: new trials by email Literature Review of Cardiac Disease trials Research Report on Cardiac Disease

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Remimazolam for TEE
Remimazolam, Propofol - Cardiac Disease, Anesthesia
Phase 4Not yet recruitingIcahn School of Medicine at Mount Sinai2102026-09-012026-09-21
Application of Radiomics for Diagnosis and Follow-up of Cardiovascular Device Infections: PREDICT Study
PET/CT imaging - Cardiac Disease, Device Related Infection
Phase 4Not yet recruitingFundacion Clinic per a la Recerca Biomédica2002026-04-302026-03-06
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
Teriparatide, DXA,VFA, X-ray, HR-pQCT, 18-F NAF PET/CT, Bone biopsy - Adynamic Bone Disease, Chronic Kidney Diseases
Phase 4RecruitingDitte Hansen482021-12-152024-04-23
Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery
Ropivacaine 0.2% Injectable Solution - New Onset Atrial Fibrillation, Anesthesia, Local
Phase 4CompletedUniversity of Minnesota322021-04-092025-08-05
Platelet Transfusion During Neonatal Open Heart Surgery
Platelet Transfusion, FFP and Cryoprecipitate, PRBC and cell saver Transfusion - Cardiac Disease, Cardiac Surgery
Phase 4CompletedThe University of Texas Health Science Center, Houston462017-04-112023-03-08
Exparel in Minimally Invasive Cardiac Surgery
Exparel infiltration - Cardiac Disease
Phase 4TerminatedMaimonides Medical Center92013-11-012019-10-04
Anesthetic Techniques in EP Patients
Propofol, Ketamine, Remifentanil - Cardiac Disease
Phase 4TerminatedUniversity of California, Los Angeles352012-05-012020-09-22
Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol
Esmolol, Metoprolol - Vascular Disease, Hypertension
Phase 4TerminatedUniversity Health Network, Toronto202011-04-012015-04-21

Narrower conditions

Heart Diseases (8)  ·  Angina Pectoris (1)  ·  Arrhythmias, Cardiac (1)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (1)  ·  Hypertension (1)  ·  Prosthesis-Related Infections (1)  ·  Renal Insufficiency, Chronic (1)  ·  Vascular Diseases (1)

Broader conditions

Cardiovascular Diseases (8)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Pathologic Processes (3)  ·  Avitaminosis (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Calcium Metabolism Disorders (1)  ·  Chest Pain (1)  ·  Chronic Disease (1)  ·  Deficiency Diseases (1)  ·  Disease Attributes (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Hyperparathyroidism (1)

Interventions

Propofol (2)  ·  Blood Specimen Collection (1)  ·  Bupivacaine (1)  ·  Factor IX (1)  ·  Heart Function Tests (1)  ·  Ketamine (1)  ·  Metoprolol (1)  ·  Platelet Count (1)  ·  Platelet Transfusion (1)  ·  Remifentanil (1)  ·  Restraint, Physical (1)  ·  Ropivacaine (1)  ·  Sevoflurane (1)  ·  Teriparatide (1)  ·  X-Rays (1)

Sponsors

Ditte Hansen (1)  ·  Fundacion Clinic per a la Recerca Biomédica (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Maimonides Medical Center (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University Health Network, Toronto (1)  ·  University of California, Los Angeles (1)  ·  University of Minnesota (1)

Countries

United States (5)  ·  Canada (1)  ·  Denmark (1)  ·  Spain (1)

Top investigators

Aman Mahajan, MD, PhD (1)  ·  Ditte Hansen, MD, PhD (1)  ·  Giuseppe Trunfio, MD (1)  ·  Himani V. Bhatt (1)  ·  James Flaherty, MD (1)  ·  Nischal K Gautam, MD (1)  ·  Scott Beattie, MD, FRCP (1)

NIH funding

2018 (1), 2025 (1)